Loading...
Products:Cell Biology >> Apoptosis >> Intracellular >> Bcl2 Family
If your product does not perform as described on this datasheet, we will refund or replace your product...
Read our guarantee »Anti-BNIP3 antibody [ANa40]
See all BNIP3 products (7) ...
Mouse monoclonal [ANa40] to BNIP3
This antibody was originally tested on whole cell lysate from 293T cells transfected with BNIP3. Levels of constitutively expressed BNIP3 are very variable and a good positive control is strongly recommended. Zhang et aln (2008) comment "Very low levels of BNIP3 protein were detected by immunoblot assay of lysates prepared from WT MEFs that were cultured at 20% O2, whereas hypoxia strongly induced expression of BNIP3 protein, which migrated as a 30-kDa monomer and 60-kDa dimer, as previously described. ... The expression of BNIP3 mRNA and protein was significantly reduced in the lungs of HET (as compared with WT) and Cre+ (as compared with Cre-) mice, demonstrating that BNIP3 expression is regulated by HIF-1 under physiological conditions in vivo."
ICC, ELISA, IP, WB, IHC-P, ICC/IFmore details
Reacts with
Mouse, Rat, Human
Recombinant fragment (Residues 1-163 of Human BNIP3).
The epitope recognized by the antibody resides within amino acids 112-124 of human BNIP3 molecule.
Whole cell lysate from 293T cells transfected with BNIP3.
Liquid
Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.
Preservative: 15mM Sodium Azide
Constituents: 0.01M PBS, pH 7.4
Concentration information loading...
Immunogen affinity purified
BNIP3, formerly NIP3 (nineteen kDa interacting protein-3), is a pro-apoptotic, mitochondrial protein classified in the Bcl 2 family based on limited sequence homology to the Bcl 2 homology 3 (BH3) domain (amino acids 110-118) and C-terminal TM domain. BNIP3 expressed in yeast and mammalian cells interacts with survival promoting proteins Bcl 2, Bcl XL, CED9 and the adenovirus E1B 19K protein. Typically the BH3 domain of pro-apoptotic Bcl-2 homologues mediates Bcl 2/Bcl XL heterodimerization and confers pro-apoptotic activity. BNIP3 represents a subfamily of Bcl 2 related proteins, which functions without a typical BH3 domain to regulate apoptosis from both mitochondrial and nonmitochondrial sites by selective Bcl 2/Bcl XL interactions. The N-terminus (residues 1-49) and the C-terminus TM domain of BNIP3 are critical for Bcl 2 heterodimerization, and either region is sufficient for Bcl XL interaction. The TM domain of BNIP3 is critical for homodimerization, pro-apoptotic function, and mitochondrial targeting. BNIP3 contains PEST sequences suggesting that the protein may be susceptible to rapid degradation by proteases. PEST sequences commonly contain high local concentrations of amino acids P, E, S, T, and D flanked by charged amino acids and these are abundantly present in NIP3. Thus, the posttranslational control of BNIP3 expression through rapid protein degradation may constitute a mechanism for regulating the intracellular levels of a potentially lethal protein. Homologues of BNIP3 sharing both structural and functional similarity have been identified in mammals: Nix (also called BNIP3L/BNIP3alpha\/B5) and, in C. elegans, ceBNIP3. The TM domain of BNIP3 and Nix share 80% identity. Endogenous BNIP3 is loosely associated with mitochondrial membrane in normal tissue but fully integrates into the mitochondrial outer membrane with the N-terminus in the cytoplasm and the C-terminus in the membrane during induction of cell death. This is accompanied by rapid and profound mitochondrial dysfunction characterized by opening of the mitochondrial permeability transition (PT) pore, proton electrochemical gradient suppression, and increased reactive oxygen species production. BNIP3 has been reported to localize to the nuclear envelope when co-expressed with E1B 19K. Endogenous BNIP3 protein is abundant in murine and human skeletal muscle and is not detectable in lysates of all other nonskeletal muscle-bearing tissues and many cell lines, including myoblasts and differentiated myocytes.
Monoclonal
ANa40
unknown
IgG2b
kappa
Metabolism >> Types of disease >> Cancer
Metabolism >> Pathways and Processes >> Metabolism processes >> Apoptosis
Metabolism >> Pathways and Processes >> Metabolism processes >> Hypoxia
Metabolism >> Pathways and Processes >> Mitochondrial Metabolism >> Mitochondrial markers
Cancer >> Cancer Metabolism >> Response to hypoxia
Cardiovascular >> Heart >> Apoptosis
Cell Biology >> Apoptosis >> Mitochondrial
Microbiology >> Interspecies Interaction >> Host Virus Interaction
Cell Biology >> Apoptosis >> Intracellular >> Bcl2 Family
Immunocytochemistry/ Immunofluorescence - Anti-BNIP3 antibody [ANa40] (ab10433)
(enlarge)
Our Abpromise guarantee covers the use of ab10433 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
ICC: Use at an assay dependent dilution.
ELISA: Use at an assay dependent dilution.
IP: Use at an assay dependent dilution.
WB: Use a concentration of 2 - 4 µg/ml. Predicted molecular weight: 21.5 kDa. Apparent molecular mass in SDS-PAGE is approximately 30 and 60 kDa, for monomer and dimer,respectively.
IHC-P: 1/400.
ICC/IF: Use at an assay dependent concentration.
Apoptosis-inducing protein that, which can overcome BCL2 suppression. May play a role in repartitioning calcium between the two major intracellular calcium stores in association with BCL2.
Belongs to the NIP3 family.
Mitochondrion. Mitochondrion membrane. Coexpression with the EIB 19-kDa protein results in a shift in NIP3 localization pattern to the nuclear envelope. Colocalizes with ACAA2 in the mitochondria.
Target information above from: UniProt accessionQ12983
The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010).
Immunocytochemistry/ Immunofluorescence - Anti-BNIP3 antibody [ANa40] (ab10433)
![Immunocytochemistry/ Immunofluorescence - Anti-BNIP3 antibody [ANa40] (ab10433)](/ps/datasheet/images/10/ab10433/BNIP3-Primary-antibodies-ab10433-6.jpg)
ab10433 staining BNIP3 in Human fibroblasts by Immunocytochemistry/ Immunofluorescence. Cells were fixed in 2% paraformaldehyde for 30 minutes at room temperature and cells were treated with 50 mM NH4Cl in PBS for 10 minutes to quench free aldehyde groups after permeabilisation. Cells were then permeabilized in 0.1% Triton X-100 prior to blocking in 1% BSA for 1 hour at room temperature. The primary antibody was diluted 1/400 and incubated with the sample for 1 hour at room temperature. The secondary antibody was Alexa Fluor®555-conjugated goat anti-mouse polyclonal, diluted 1/1000.
This image is courtesy of an Abreview submitted by Sharon Sneddon.
This product has been referenced in:
See all 16 publications for this product
Publishing research using ab10433? Please let us know so that we can cite the reference in this datasheet
Concentration of lot no. is
Concentration not available for this lot.
Find concentration of your lot:
![Immunocytochemistry/ Immunofluorescence - Anti-BNIP3 antibody [ANa40] (ab10433)](/ps/datasheet/images/10/ab10433/BNIP3-Primary-antibodies-ab10433-6.jpg)
ab10433 staining BNIP3 in Human fibroblasts by Immunocytochemistry/ Immunofluorescence. Cells were fixed in 2% paraformaldehyde for 30 minutes at room temperature and cells were treated with 50 mM NH4Cl in PBS for 10 minutes to quench free aldehyde groups after permeabilisation. Cells were then permeabilized in 0.1% Triton X-100 prior to blocking in 1% BSA for 1 hour at room temperature. The primary antibody was diluted 1/400 and incubated with the sample for 1 hour at room temperature. The secondary antibody was Alexa Fluor®555-conjugated goat anti-mouse polyclonal, diluted 1/1000.
This image is courtesy of an Abreview submitted by Sharon Sneddon.
2
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"
Call 01223 696 000 or contact us
